Published “Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study” in The Lancet Neurology — cited 779 times.
- #crossref
- #research
- #work